Covered recipient · General Payments record
LAURA FLANAGAN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Women's Health
General Payments · PY2021–2024
$1,080.03
- Reported across 49 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $598.84 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Biogen, Inc. | $208.75 | 8 |
| Daiichi Sankyo Inc. | $171.15 | 9 |
| Astellas Pharma US Inc | $73.24 | 3 |
| Exeltis, USA Inc. | $60.87 | 3 |
| Axonics Modulation Technologies, Inc. | $30.16 | 1 |
| PFIZER INC. | $21.67 | 1 |
| Evofem Biosciences, Inc. | $17.46 | 1 |
| Sumitomo Pharma America, Inc. | $15.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $21.68 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139461974 | CMS |
| Astellas Pharma US Inc | $16.58 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139498852 | CMS |
| Astellas Pharma US Inc | $34.98 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139513673 | CMS |
| Axonics, Inc. | $30.16 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142394761 | CMS |
| Biogen, Inc. | $23.58 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104805711 | CMS |
| Biogen, Inc. | $25.98 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104811297 | CMS |
| Biogen, Inc. | $27.74 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104846708 | CMS |
| Biogen, Inc. | $29.76 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104851322 | CMS |
| Biogen, Inc. | $27.31 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104867314 | CMS |
| Biogen, Inc. | $23.60 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104811299 | CMS |
| Biogen, Inc. | $24.32 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104867316 | CMS |
| Biogen, Inc. | $26.46 | 11/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104849042 | CMS |
| Daiichi Sankyo Inc. | $28.32 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089421910 | CMS |
| Daiichi Sankyo Inc. | $20.79 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089421912 | CMS |
| Daiichi Sankyo Inc. | $20.13 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089421906 | CMS |
| Daiichi Sankyo Inc. | $8.19 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089421908 | CMS |
| Daiichi Sankyo Inc. | $19.21 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089421914 | CMS |
| Daiichi Sankyo Inc. | $16.76 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089421916 | CMS |
| Daiichi Sankyo Inc. | $6.92 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089421896 | CMS |
| Daiichi Sankyo Inc. | $26.80 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089421898 | CMS |
| Daiichi Sankyo Inc. | $24.03 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089421900 | CMS |
| Evofem Biosciences, Inc. | $17.46 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091275724 | CMS |
| Exeltis, USA Inc. | $18.71 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150012135 | CMS |
| Exeltis, USA Inc. | $21.72 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150012137 | CMS |
| Exeltis, USA Inc. | $20.44 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150012139 | CMS |
| PFIZER INC. | $21.67 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131953582 | CMS |
| Sumitomo Pharma America, Inc. | $15.54 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148959630 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.